December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
8 Posts From ANZUP24 That You Should Not Miss!
Jul 25, 2024, 11:12

8 Posts From ANZUP24 That You Should Not Miss!

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) organized their ANZUP24 Annual Scientific Meeting (ASM) from 2st to 23rd July 2024.

Our team at OncoDaily has shortlisted a few highlights from ANZUP24 that you should not miss.

Miku Kuba:

Absolute pleasure to be able to attend ANZUP24! Lots of great talks, great people, and lovely weather. Thanks also to ANZUP trials for the Study Coordinator scholarship, of which I was a recipient for this year.

ANZUP24

Shomik Sengupta:

Great disparities in Asia-Pacific countries highlighted by Ravindran Kanesvaran – strong need for cross-border initiatives to improve equity.

ANZUP24

Rhea Liang:

What a joy to speak at ANZUP24 today and finally meet Ian Davis (who founded ANZUP trials). Many Thanks to Niara Oliviera and Carole Harris for organising, and to co-panellists Fiona Maclean
and Liz Kenny for a discussion that could have continued for hours.

ANZUP24

Cristiane D Bergerot:

Compelling talk by Haitham Tuffaha on translating these insights into public policy and other health economic considerations. Essential for shaping patient-centered oncology care!

ANZUP24

Kheng Soo:

Deeply honoured to receive the ANZUP24 Synchrony Fellowship for project on frailty and quality of life in prostate cancer. Truly grateful to ANZUP and donors for their generous support! Excited to advance this important research.

ANZUP24

Paul Nguyen:

Amazing example of work-life integration by Cristiane D Bergerot and Paulo Bergerot giving great talks back to back on the plenary stage at ANZUP24 while caring for their young daughter in the front row!

ANZUP24

Shomik Sengupta:

Current state of management of metastatic prostate cancer: ongoing and upcoming clinical trials assessing new drugs, SABR, theranostics and de-escalation.

Image

Paulo Bergerot:

I’m truly proud and happy to be here at the ANZUP24 to present results from our study of Exercise Oncology patients with Kidney Cancer on ICI. Many thanks to the ANZUP, Cristiane D Bergerot, Ian Davis, Sumanta K. Pal and Kathryn Schmitz.

ANZUP24